Literature DB >> 14557962

Neisseria meningitidis carriage during an outbreak of serogroup C disease.

David M Patrick1, Sylvie Champagne, Swee-Han Goh, Gillian Arsenault, Eva Thomas, Carol Shaw, Tazim Rahim, Fatma Taha, Mark Bigham, Valerie Dubenko, Danuta Skowronski, Robert C Brunham.   

Abstract

During 2001, an outbreak of serogroup C meningococcal disease led to immunization of individuals aged 13-29 years in Abbotsford, British Columbia, Canada. This study addresses the distribution of Neisseria meningitidis carriage in this population and the implications of that distribution for the targeting of the immunization campaign. Pharyngeal swabs were obtained at immunization from 2004 people. Colonies were identified and serogrouped using standard agglutination methods and by PCR. Isolates were characterized using pulsed-field gel electrophoresis (PFGE). The prevalence of N. meningitidis carriage was 153 carriers per 2004 subjects (7.6%; 95% confidence interval, 6.5%-8.9%). Only 6 (4%) of the isolates from these carriers were found to be serogroup C by agglutination or PCR testing, and all of these were from individuals within the age group targeted for immunization. Only 1 of these 6 isolates was found to be identical to the outbreak strain by PFGE. The observation that a virulent strain is not circulating widely suggests the possibility of low background immunity in the population at risk and emphasizes the importance of vaccination in controlling epidemic group C meningococcal disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14557962     DOI: 10.1086/378743

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  16 in total

1.  Genetic and antigenic analysis of invasive serogroup C Neisseria meningitidis in Canada: A decrease in the electrophoretic type (ET)-15 clonal type and an increase in the proportion of isolates belonging to the ET-37 (but not ET-15) clonal type during the period from 2002 to 2009.

Authors:  Jianwei Zhou; Frances Jamieson; Sharon Dolman; Linda Mn Hoang; Prasad Rawte; Raymond Sw Tsang
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

2.  Distribution of serogroups and genotypes among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway.

Authors:  Siamak P Yazdankhah; Paula Kriz; Georgina Tzanakaki; Jenny Kremastinou; Jitka Kalmusova; Martin Musilek; Torill Alvestad; Keith A Jolley; Daniel J Wilson; Noel D McCarthy; Dominique A Caugant; Martin C J Maiden
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

3.  The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance.

Authors:  Guillermo Madico; Jo Anne Welsch; Lisa A Lewis; Anne McNaughton; David H Perlman; Catherine E Costello; Jutamas Ngampasutadol; Ulrich Vogel; Dan M Granoff; Sanjay Ram
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

4.  The prevalence, serogroup distribution and risk factors of meningococcal carriage in adolescents and young adults in Turkey.

Authors:  Rahmi Tuna Tekin; Ener Cagri Dinleyici; Mehmet Ceyhan; Adem Karbuz; Nuran Salman; Murat Sutçu; Zafer Kurugol; Yasemin Balliel; Melda Celik; Mustafa Hacimustafaoglu; Necdet Kuyucu; Meda Kondolot; Gülnar Sensoy; Ozge Metin; Soner Sertan Kara; Meltem Dinleyici; Omer Kılıç; Cihangul Bayhan; Venhar Gurbuz; Emre Aycan; Aygun Memedova; Arzu Karli; Gulçin Bozlu; Solmaz Celebi
Journal:  Hum Vaccin Immunother       Date:  2017-01-31       Impact factor: 3.452

5.  Analysis of phenotypic variants of the serogroup C ET-15 clone of Neisseria meningitidis by pulsed-field gel electrophoresis.

Authors:  Marissa L Cameron; Raymond S W Tsang
Journal:  J Clin Microbiol       Date:  2007-05-09       Impact factor: 5.948

6.  Usefulness of pulsed-field gel electrophoresis in tracking two outbreaks of invasive meningococcal disease serogroup C in British Columbia.

Authors:  Grahame Quan; Mark Gilbert; Samara T David; Tazim Rahim; Kathy Adie; Carol Shaw; Alan McNabb; Judy Isaac-Renton; David M Patrick
Journal:  Can J Infect Dis Med Microbiol       Date:  2007-11       Impact factor: 2.471

7.  Vaccine strategies of meningococcal disease: results of a 10-year population-based study.

Authors:  Ariane Biebl; Gabriele Hartmann; Christian Bernhard; Elmar Bechter; Anita Luckner-Hornischer; Martin Frühwirth; Sigrid Heuberger; Felix Offner; Verena Barbieri; Burkhard Simma
Journal:  Eur J Pediatr       Date:  2005-08-27       Impact factor: 3.183

8.  Profile of serogroup Y meningococcal infections in Canada: Implications for vaccine selection.

Authors:  Nicole Le Saux; Julie A Bettinger; Susan Wootton; Scott A Halperin; Wendy Vaudry; David W Scheifele; Raymond Tsang
Journal:  Can J Infect Dis Med Microbiol       Date:  2009       Impact factor: 2.471

9.  Meningococcal carriage during a clonal meningococcal B outbreak in France.

Authors:  V Delbos; L Lemée; J Bénichou; G Berthelot; M-K Taha; F Caron
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-06-02       Impact factor: 3.267

10.  Sex bias in infectious disease epidemiology: patterns and processes.

Authors:  Felipe Guerra-Silveira; Fernando Abad-Franch
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.